Clearside Biomedical Is Maintained at Buy by Chardan Capital

Dow JonesNov 16 06:52 · Ratings

JonesTrading Maintains Clearside Biomedical(CLSD.US) With Buy Rating, Maintains Target Price $6

Futu NewsNov 13 22:33 · Ratings

Promising Outlook for Clearside Biomedical: Buy Rating Backed by Strong Phase 2b ODYSSEY Trial Data and Robust Cash Position

TipRanksNov 13 21:45 · Ratings

Oppenheimer Maintains Clearside Biomedical(CLSD.US) With Buy Rating, Maintains Target Price $5

Futu NewsNov 13 21:36 · Ratings

Needham Maintains Clearside Biomedical(CLSD.US) With Buy Rating, Maintains Target Price $6

Futu NewsNov 13 20:35 · Ratings

Needham Reiterates Buy on Clearside Biomedical, Maintains $6 Price Target

BenzingaNov 13 19:46 · Ratings